Around 30 days for near-complete elimination, based on the 5 half-life rule
Across remaining preclinical and animal studies, risk of bias was generally moderate, driven by small sample sizes, lack of explicit randomization or blinding, and indirectness to human metabolic outcomes
In many ways, GLP-1 Read More GLP-1 Therapy and Sleep: Could Metabolic Drugs Improve Sleep Quality
The chronic pain problem: where the evidence and the biology diverge The most common leap I see is the leap from maybe helpful for an acute tendon injury to maybe helpful for arthritis, chronic knee pain, or long-standing degenerative issues. This is where I think the case is weak
I have always had the ick when it comes to needles but, when I tell you, the IV hydration is worth conquering the fear
For example, CordenPharma announced a collaboration with PeptiSystems in 2022 that involved a continuous manufacturing synthesis approach for GLP-1RAs that reduces solvent consumption and corresponding waste production by 40%